JP2009525292A5 - - Google Patents

Download PDF

Info

Publication number
JP2009525292A5
JP2009525292A5 JP2008552729A JP2008552729A JP2009525292A5 JP 2009525292 A5 JP2009525292 A5 JP 2009525292A5 JP 2008552729 A JP2008552729 A JP 2008552729A JP 2008552729 A JP2008552729 A JP 2008552729A JP 2009525292 A5 JP2009525292 A5 JP 2009525292A5
Authority
JP
Japan
Prior art keywords
pyrido
pyrimidin
alkyl
phenylamino
tolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2008552729A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009525292A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/000725 external-priority patent/WO2007088014A1/en
Publication of JP2009525292A publication Critical patent/JP2009525292A/ja
Publication of JP2009525292A5 publication Critical patent/JP2009525292A5/ja
Ceased legal-status Critical Current

Links

JP2008552729A 2006-01-31 2007-01-29 7h−ピリド[3,4−d]ピリミジン−8−オン、それらの製造及びプロテインキナーゼ阻害剤としての使用 Ceased JP2009525292A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06001915 2006-01-31
PCT/EP2007/000725 WO2007088014A1 (en) 2006-01-31 2007-01-29 7h-pyrido[3,4-d]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors

Publications (2)

Publication Number Publication Date
JP2009525292A JP2009525292A (ja) 2009-07-09
JP2009525292A5 true JP2009525292A5 (https=) 2012-01-26

Family

ID=36609592

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008552729A Ceased JP2009525292A (ja) 2006-01-31 2007-01-29 7h−ピリド[3,4−d]ピリミジン−8−オン、それらの製造及びプロテインキナーゼ阻害剤としての使用

Country Status (13)

Country Link
US (1) US8058283B2 (https=)
EP (1) EP1981886B1 (https=)
JP (1) JP2009525292A (https=)
KR (1) KR20080083046A (https=)
CN (1) CN101374840B (https=)
AT (1) ATE439361T1 (https=)
AU (1) AU2007211684A1 (https=)
BR (1) BRPI0706781A2 (https=)
CA (1) CA2636981A1 (https=)
DE (1) DE602007001952D1 (https=)
ES (1) ES2329419T3 (https=)
IL (1) IL191748A0 (https=)
WO (1) WO2007088014A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2329419T3 (es) 2006-01-31 2009-11-25 F. Hoffmann-La Roche Ag 7h-pirido(3,4-d)pirimidin-8-onas, su preparacion y uso como inhibidores de proteinas cinasas.
SA111320200B1 (ar) 2010-02-17 2014-02-16 ديبيوفارم اس ايه مركبات ثنائية الحلقة واستخداماتها كمثبطات c-src/jak مزدوجة
MX2014010176A (es) * 2012-02-23 2014-11-10 Abbvie Inc Inhibidores de cinasas de piridopirimidinona.
JP6280546B2 (ja) 2012-06-26 2018-02-14 デル マー ファーマシューティカルズ ジアンヒドロガラクチトール、ジアセチルジアンヒドロガラクチトール、ジブロモズルシトール、又はこれらの類似体若しくは誘導体を用いた、遺伝子多型又はahi1の調節不全若しくは変異を有する患者におけるチロシンキナーゼインヒビター抵抗性悪性腫瘍を処置するための方法
CN105130986B (zh) * 2015-09-30 2017-07-18 广州科擎新药开发有限公司 嘧啶或吡啶并吡啶酮类化合物及其应用
CN110016026B (zh) * 2018-01-08 2022-11-25 上海凌济生物科技有限公司 一类具有抗肿瘤活性的嘧啶并吡啶酮类化合物、制备方法和用途
KR102747104B1 (ko) * 2019-02-18 2024-12-27 한국과학기술연구원 단백질 키나아제 저해 활성을 갖는 신규한 피리도[3,4-d]피리미딘-8-온 유도체 및 이를 포함하는 암의 예방, 개선 또는 치료용 약학 조성물
KR102329720B1 (ko) 2019-08-30 2021-11-23 한국과학기술연구원 단백질 키나아제 저해 활성을 갖는 신규한 피리미도[4,5-d]피리미딘-2-온 유도체

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL181893B1 (pl) 1994-11-14 2001-10-31 Warner Lambert Co Zwiazki bedace pochodnymi pirymidyny i naftyrydyny oraz preparat farmaceutyczny zawierajacy je PL PL PL
IL117923A (en) 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
RS49779B (sr) * 1998-01-12 2008-06-05 Glaxo Group Limited, Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
TR200003429T2 (tr) 1998-05-26 2001-07-23 Warner-Lambert Company Hücresel çoğalma inhibitörleri olarak bisiklik pirimidinler ve bisiklik 3,4-dihidropirimidinler.
HK1041483B (zh) 1998-10-23 2004-12-24 霍夫曼-拉罗奇有限公司 雙環氮雜環
AU776250B2 (en) 1999-10-21 2004-09-02 F. Hoffmann-La Roche Ag Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
CZ20021743A3 (cs) 1999-10-21 2002-08-14 F. Hoffmann-La Roche Ag Bicyklické dusíkové heterocykly substituované alkylaminoskupinou jako inhibitory P38 proteinkinázy
CA2420122A1 (en) 2000-08-31 2002-03-07 F. Hoffmann-La Roche Ag 7-oxo pyridopyrimidines
CA2420286A1 (en) 2000-08-31 2002-03-07 F. Hoffmann-La Roche Ag 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation
US7196090B2 (en) 2002-07-25 2007-03-27 Warner-Lambert Company Kinase inhibitors
US7112676B2 (en) 2002-11-04 2006-09-26 Hoffmann-La Roche Inc. Pyrimido compounds having antiproliferative activity
TW200413381A (en) 2002-11-04 2004-08-01 Hoffmann La Roche Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
CL2004000366A1 (es) 2003-02-26 2005-01-07 Pharmacia Corp Sa Organizada B USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA.
WO2004089955A1 (en) 2003-04-10 2004-10-21 F.Hoffmann-La Roche Ag Pyrimido compounds
WO2005011597A2 (en) 2003-07-29 2005-02-10 Irm Llc Compounds and compositions as protein kinase inhibitors
AU2004279427B2 (en) 2003-10-08 2008-07-03 Irm Llc Compounds and compositions as protein kinase inhibitors
WO2006012577A2 (en) * 2004-07-22 2006-02-02 Bayer Pharmaceuticals Corporation Quinazolinone derivatives useful for the regulation of glucose homeostasis and food intake
ES2329419T3 (es) 2006-01-31 2009-11-25 F. Hoffmann-La Roche Ag 7h-pirido(3,4-d)pirimidin-8-onas, su preparacion y uso como inhibidores de proteinas cinasas.

Similar Documents

Publication Publication Date Title
JP2009525292A5 (https=)
ES2985528T3 (es) Nuevos compuestos y composiciones farmacéuticas de los mismos para el tratamiento de enfermedades
ES2908283T3 (es) Nuevos compuestos y composiciones farmacéuticas de los mismos para el tratamiento de enfermedades
JP5630867B2 (ja) イミダゾピリジン−2−オン誘導体
RU2675818C2 (ru) Новые соединения и фармацевтические композиции, их содержащие, для лечения воспалительных расстройств
JP2022552873A5 (https=)
ES2638850T3 (es) Compuestos de azabenzimidazol como inhibidores de las isoenzimas de la PDE4 para el tratamiento de trastornos del SNC y otros trastornos
ES2703934T3 (es) Compuesto de pirrolo[2,1-f][1,2,4]triazina y procedimiento de preparación y aplicación del mismo
JP2011507854A5 (https=)
AU2018350980B2 (en) Condensed imidazole derivatives substituted by tertiary hydroxy groups as pi3k-y gamma inhibitors
JP2012514631A5 (https=)
CN107108614A (zh) 作为布罗莫结构域抑制剂的取代的吡咯并吡啶
JP2004527560A5 (https=)
TWI689496B (zh) 治療發炎疾病之新穎化合物及其醫藥組合物
JP2012512887A5 (https=)
JP6506833B2 (ja) イミダゾピリダジン化合物
JP2017513879A5 (https=)
RU2013151803A (ru) Бициклические гетероциклические соединения и их применения в терапии
EP2224929B1 (en) Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1
EP3601281A1 (en) Crystalline forms of 4-(1-(1,1-di(pyridin-2-yl)ethyl)-6-(3,5-dimethylisoxazol-4-yl)-1h- pyrrolo[3,2-b]pyridin-3-yl)benzoic acid that inhibits bromodomain
KR20170103838A (ko) 염증 및 암의 치료를 위한 헤테로시클릭 itk 저해제
EA035601B1 (ru) Бициклические ингибиторы бромодомена
WO2016077378A1 (en) Substituted pyrrolopyrdines as inhibitors of bromodomain
JP2013523710A5 (https=)
AR087336A1 (es) Compuestos de 2-(2,4,5-anilino sustituido)pirimidina